CMS to scruntinize Medicare formularies

In evaluating and approving proposals from Medicare prescription drug plans (PDPs), CMS says it will examine a plan's formulary list, pharmacy and therapeutics (P&T) committee operations, and benefit management tools, such as prior authorization and appeals and exceptions policies.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.